File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Prospective Assessment of Penicillin Allergy (PAPA): Evaluating the performance of penicillin allergy testing and post-delabelling outcomes among Hong Kong Chinese

TitleProspective Assessment of Penicillin Allergy (PAPA): Evaluating the performance of penicillin allergy testing and post-delabelling outcomes among Hong Kong Chinese
Authors
Issue Date23-Apr-2023
PublisherAllergy and Immunology Society of Thailand
Citation
Asian Pacific Journal of Allergy and Immunology, 2023 How to Cite?
Abstract

Background: Incorrect penicillin ‘allergy’ labels predispose patients to adverse outcomes but are under-recognised in many Asian countries. Studies on performance and post-delabelling outcomes of penicillin allergy evaluation among Chinese remain scarce. Objective: To evaluate the diagnostic performance of allergy testing and post-delabelling outcomes among Chinese patients in a prospective penicillin allergy cohort – Prospective Assessment of Penicillin Allergy (PAPA). Methods: All adult patients (age ≥ 18 years) who underwent penicillin allergy evaluation between January 2020 to December 2021 were recruited and prospectively reviewed by both medical records and individual interviews at least 6 months after delabelling or allergy confirmation. Results: Out of 372 patients who completed penicillin allergy evaluation, 335 (90%) patients were delabelled. The overall negative predictive value of penicillin skin testing was 95%, but lower for patients with non-immediate type reactions (88%). History of non-immediate symptom onset (OR = 4.501 [95%CI = 2.085-9.716], p < 0.001) and duration since index reaction (OR = 0.942 [95%CI = 0.899-0.987], p = 0.012) were associated with positive skin testing. After at least 6 months, 60 (18%) of de-labelled patients had received penicillins again without any adverse reactions. Fluoroquinolone-use was significantly lower among delabelled patients compared to those with penicillin allergy (38[11%] vs 11[30%], p = 0.004). Conclusion: After at least 6 months, one in six delabelled patients already received penicillins again safely, with significantly lower fluoroquinolone usage. None experienced adverse reactions. History of non-immediate onset and shorter duration since index reaction were associated with genuine allergy. In patients with severe non-immediate reactions, skin tests should be supplemented with thorough clinical history and adjunct diagnostic evaluations. Key words: Allergy, Penicillin, Delabelling, Outcome, Prospective Study


Persistent Identifierhttp://hdl.handle.net/10722/331468
ISSN
2023 Impact Factor: 2.3
2023 SCImago Journal Rankings: 0.605

 

DC FieldValueLanguage
dc.contributor.authorLi, Tin Sum-
dc.contributor.authorHui, Harris KS-
dc.contributor.authorKan, Andy Ka Chun-
dc.contributor.authorYeung, Maegan HY-
dc.contributor.authorWong, Jane CY-
dc.contributor.authorChiang, Valerie-
dc.contributor.authorLi, Philip Hei-
dc.date.accessioned2023-09-21T06:56:00Z-
dc.date.available2023-09-21T06:56:00Z-
dc.date.issued2023-04-23-
dc.identifier.citationAsian Pacific Journal of Allergy and Immunology, 2023-
dc.identifier.issn0125-877X-
dc.identifier.urihttp://hdl.handle.net/10722/331468-
dc.description.abstract<p>Background: Incorrect penicillin ‘allergy’ labels predispose patients to adverse outcomes but are under-recognised in many Asian countries. Studies on performance and post-delabelling outcomes of penicillin allergy evaluation among Chinese remain scarce. Objective: To evaluate the diagnostic performance of allergy testing and post-delabelling outcomes among Chinese patients in a prospective penicillin allergy cohort – Prospective Assessment of Penicillin Allergy (PAPA). Methods: All adult patients (age ≥ 18 years) who underwent penicillin allergy evaluation between January 2020 to December 2021 were recruited and prospectively reviewed by both medical records and individual interviews at least 6 months after delabelling or allergy confirmation. Results: Out of 372 patients who completed penicillin allergy evaluation, 335 (90%) patients were delabelled. The overall negative predictive value of penicillin skin testing was 95%, but lower for patients with non-immediate type reactions (88%). History of non-immediate symptom onset (OR = 4.501 [95%CI = 2.085-9.716], p < 0.001) and duration since index reaction (OR = 0.942 [95%CI = 0.899-0.987], p = 0.012) were associated with positive skin testing. After at least 6 months, 60 (18%) of de-labelled patients had received penicillins again without any adverse reactions. Fluoroquinolone-use was significantly lower among delabelled patients compared to those with penicillin allergy (38[11%] vs 11[30%], p = 0.004). Conclusion: After at least 6 months, one in six delabelled patients already received penicillins again safely, with significantly lower fluoroquinolone usage. None experienced adverse reactions. History of non-immediate onset and shorter duration since index reaction were associated with genuine allergy. In patients with severe non-immediate reactions, skin tests should be supplemented with thorough clinical history and adjunct diagnostic evaluations. Key words: Allergy, Penicillin, Delabelling, Outcome, Prospective Study<br></p>-
dc.languageeng-
dc.publisherAllergy and Immunology Society of Thailand-
dc.relation.ispartofAsian Pacific Journal of Allergy and Immunology-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.titleProspective Assessment of Penicillin Allergy (PAPA): Evaluating the performance of penicillin allergy testing and post-delabelling outcomes among Hong Kong Chinese-
dc.typeArticle-
dc.identifier.doi10.12932/AP-270922-1469-
dc.identifier.issnl0125-877X-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats